Factors | Cancer-Specific Survival | Disease-Free Survival | Overall Survival | |||
---|---|---|---|---|---|---|
 | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P |
P-LVD | 2.099(0.91-4.87) | 0.084 | 2.418(1.08-5.40) | 0.031 | 2.895 (1.02-8.19) | 0.045 |
I-LVD | 1.205(0.56-2.63) | 0.639 | 1.325(0.62-2.85) | 0.472 | 1.959 (0.90-4.24) | 0.088 |
VEGF-A | 1.386(0.50-3.83) | 0.528 | 1.364(0.67-2.78) | 0.391 | 2.437(1.10-5.45) | 0.030 |
VEGF-C | 2.423(0.89-6.63) | 0.085 | 1.630(0.77-3.47) | 0.205 | 1.562 (0.79-3.34) | 0.182 |
VEGF-D | 0.511(0.19-1.36) | 0.178 | 1.916(0.90-4.10) | 0.094 | 1.621 (0.81-3.98) | 0.190 |
LVI | 2.716 (1.05-7.04) | 0.040 | 2.477(1.03-5.97) | 0.043 | 2.578 (1.05-6.34) | 0.039 |
LNM | 2.115(0.68-6.60) | 0.197 | 2.428(1.18-5.02) | 0.017 | 3.426 (1.66-7.06) | 0.001 |
VI | 2.943(0.89-9.77) | 0.078 | 1.697(0.75-3.87) | 0.208 | 1.477(0.63-3.48) | 0.373 |
P-VEGFR-3 | 1. 499(0.98-2.31) | 0.067 | 1.099(0.53-2.28) | 0.800 | 1.402 (0.68-2.90) | 0.361 |
TNM stage | 1.523(1.00-2.31) | 0.048 | 1.674(1.25-2.25) | 0.001 | 1.656(1.23-2.23) | 0.001 |